Drugplain

LBEL DIVINE Double Use compact SPF 15 gold deluxe edition Obscure 8-9 3 g/100g

Zinc oxide, Titantium dioxide, Octinoxate · POWDER · Bel Star S.A. (Colombia)

No Recall History
Plain English

This is a compact powder foundation with sunscreen that you apply to your skin to provide coverage and sun protection. It contains mineral and chemical sunscreen ingredients that help protect against UV rays.

Key Facts

Brand Name
LBEL DIVINE Double Use compact SPF 15 gold deluxe edition Obscure 8-9
Generic Name
Zinc oxide, Titantium dioxide, Octinoxate
NDC Code (Product)
14141-206
Manufacturer
Bel Star S.A. (Colombia)
Strength
3 g/100g
Dosage Form
POWDER
Route
TOPICAL
Marketing Status
Application #
M020
Marketing Start
11/12/2020

Recall History

No Recall History

Frequently Asked Questions

What is LBEL DIVINE Double Use compact SPF 15 gold deluxe edition Obscure 8-9 used for?

This is a compact powder foundation with sunscreen that you apply to your skin to provide coverage and sun protection. It contains mineral and chemical sunscreen ingredients that help protect against UV rays.

Is LBEL DIVINE Double Use compact SPF 15 gold deluxe edition Obscure 8-9 a controlled substance?

LBEL DIVINE Double Use compact SPF 15 gold deluxe edition Obscure 8-9 is not classified as a controlled substance by the DEA.

What is the generic name for LBEL DIVINE Double Use compact SPF 15 gold deluxe edition Obscure 8-9?

The generic name for LBEL DIVINE Double Use compact SPF 15 gold deluxe edition Obscure 8-9 is Zinc oxide, Titantium dioxide, Octinoxate. There are no other listed brand versions of Zinc oxide, Titantium dioxide, Octinoxate.

What is the NDC code for LBEL DIVINE Double Use compact SPF 15 gold deluxe edition Obscure 8-9 3 g/100g?

The NDC (National Drug Code) for LBEL DIVINE Double Use compact SPF 15 gold deluxe edition Obscure 8-9 3 g/100g is 14141-206, listed by Bel Star S.A. (Colombia).

Product NDC

14141-206

Package NDC

14141-206-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)